The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SARCLISA isatuximab 100 mg/5 mL concentrated injection vial (319086)
ARTG Name
SARCLISA isatuximab 100 mg/5 mL concentrated injection vial
Product name
SARCLISA isatuximab 100 mg/5 mL concentrated injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
isatuximab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information